Human/Mouse/Rat TOR Antibody Summary
Phe1720-Ala2020
Accession # P42345
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Human/Mouse/Rat TOR by Western Blot. Western blot shows lysates of MCF-7 human breast cancer cell line, Balb/3T3 mouse embryonic fibroblast cell line, and NRK rat normal kidney cell line. PVDF membrane was probed with 1 µg/mL of Human/Mouse/Rat TOR Antigen Affinity-purified Polyclonal Antibody (Catalog # AF15371) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for TOR at approximately 280 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TOR
The Target of Rapamycin (TOR) is a member of the PI 3-kinase-related kinase (PIKK) family. TOR is the protein target of rapamycin, an anti-rejection drug used in transplantation and promising anti-cancer agent. TOR plays a crucial role in the control of cell growth and proliferation as a downstream target of the PI 3-kinase/Akt signal transduction pathway.
Product Datasheets
Citations for Human/Mouse/Rat TOR Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
4
Citations: Showing 1 - 4
Filter your results:
Filter by:
-
Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization.
Authors: Park Tae Kwann, Lee Si Hyung, Choi Jun Sub et al.
Molecular Therapy. Nucleic Acids
-
mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
Authors: SHS Lee, JY Lee, JS Choi, HJ Kim, J Kim, S Cha, KJ Lee, HN Woo, K Park, H Lee
PLoS ONE, 2022-06-16;17(6):e0269951.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC -
Inhibition of mTOR via an AAV-Delivered shRNA Tested in a Rat OIR Model as a Potential Antiangiogenic Gene Therapy
Authors: SHS Lee, H Chang, JH Kim, HJ Kim, JS Choi, S Chung, HN Woo, KJ Lee, K Park, JY Lee, H Lee
Invest. Ophthalmol. Vis. Sci., 2020-02-07;61(2):45.
Species: Rat
Sample Types: Whole Tissue
Applications: IHC -
Effects of Stuffer DNA on the Suppression of Choroidal Neovascularization by a rAAV Expressing a mTOR-Inhibiting shRNA
Authors: Steven Hyun Seung Lee, HeeSoon Chang, Hee Jong Kim, Jun-Sub Choi, Jin Kim, Ji Hyun Kim et al.
Molecular Therapy - Methods & Clinical Development
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human/Mouse/Rat TOR Antibody
There are currently no reviews for this product. Be the first to review Human/Mouse/Rat TOR Antibody and earn rewards!
Have you used Human/Mouse/Rat TOR Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image